Cargando…

RELATIONSHIP BETWEEN PARVOVIRUS B19 AND OSTEOARTHRITIS: LITERATURE REVIEW

Osteoarthritis and Parvovirus B19 infection present silent and gradual evolution, since the former is a degenerative process while the latter is often asymptomatic and may persist in the individual’s body during their life. This study aims to analyze clinical studies that establish a correlation bet...

Descripción completa

Detalles Bibliográficos
Autores principales: MARQUES, GUILHERME LOTERIO, DURIGON, THOMAS STRAVINSKAS, SARTI, FERNANDA CRISTINA DE SANTANA E, MORETTO, RENATO TADEU SASSMANNSHAUSEN, JANA NETO, FREDERICO CARLOS, FALÓTICO, GUILHERME GUADAGNINI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ATHA EDITORA 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353865/
https://www.ncbi.nlm.nih.gov/pubmed/37469492
http://dx.doi.org/10.1590/1413-785220233103e267046
Descripción
Sumario:Osteoarthritis and Parvovirus B19 infection present silent and gradual evolution, since the former is a degenerative process while the latter is often asymptomatic and may persist in the individual’s body during their life. This study aims to analyze clinical studies that establish a correlation between degenerative osteoarthritis and Parvovirus B19 infection. Of the 62 studies found, 25 were chosen for reading in full. Analyzing only the studies that establish the correlation between the pathologies, seven confirm this relationship between Parvovirus B19 and Osteoarthritis, while one reports no relationship. No objective correlation could be found between the other articles studied. Our findings suggest that there is a close relationship between Parvovirus B19 and Osteoarthritis, with a higher prevalence of acquired causes, women and older adults, but it can manifest during life. However, it is essential to carry out new studies involving family history of patients with Osteoarthritis with positivity of Parvovirus B19, cohort studies between childhood and adult-old adult, so that it can elucidate this duality of congenital-acquired cause and, finally, raise treatment alternatives. Level of Evidence II, Systematic Review of Level II Studies.